Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts

Ruths, Sabine; Sørensen, Pernille Hegre; Kirkevold, Øyvind; Husebø, Bettina S.; Krüger, Kjell; Halvorsen, Kjell H.; Selbæk, Geir

doi:10.1002/gps.3902

Cited by 52 publications

(64 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…27,35 This study's observation that 12.1% of people ≥65 years old were prescribed one or more B&Zs, that is, one in four of the care home population and one in nine of the non-care home residents, with care home residents approximately three times more likely to have a B&Z prescribed, is also comparable to the wider literature, 2,25,[27][28][29]37 but is lower than that found among a Canadian sample. 1 This study found anxiolytic prescribing for non-care home residents to be comparable with previous studies.…”

Section: Comparison With Existing Literaturesupporting

confidence: 64%

“…However, more personalised data are available for health boards and approved researchers. As with other studies of this nature, the lack of information on drug indications linked to prescribing is a limiting factor, 1,2,[27][28][29]35 but details of prescription indications in patients' clinical notes are known to be incomplete or lacking. 24 This may improve with the introduction of the Scottish Primary Care Resource (SPIRE), a collaboration between the Scottish Government and NHS National Services Scotland to simplify and standardise the process for extracting data from GP practice systems for audit, disease surveillance, benchmarking, planning, and research.…”

Section: 3 Lormetazepam (S) or Zaleplon (S)mentioning

confidence: 99%

“…23,24 Previous UK and international studies indicate that up to 33% of people ≥65 years may be prescribed B&Zs, and that older people with dementia are twice as likely to be prescribed these drugs, with care home residents being two to three times more likely. [25][26][27][28][29] These studies were largely conducted at a regional level and were possibly influenced by local policy, drug availability, and routine practice. The current study, however, aims to compare B&Z prescribing between care home and non-care home residents aged ≥65 years, at regional and national levels across Scotland.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study

et al. 2016

View full text Add to dashboard Cite

Background Overall prescribing of benzodiazepines and z-hypnotics (B&Zs) has slowly reduced over the past 20 years. However, long-term prescribing still occurs, particularly among older people, and this is at odds with prescribing guidance. Aim To compare prescribing of B&Zs between care home and non-care home residents ≥65 years old. Design and setting Cross-sectional population-based study in primary care in Scotland. Method National patient-level B&Z prescribing data, for all adults aged ≥65 years, were extracted from the Prescribing Information System (PIS) for the calendar year 2011. The PIS gives access to data for all NHS prescriptions dispensed in primary care in Scotland. Data were stratified by health board, residential status, sex, and age (65–74, 75–84, and ≥85 years). To minimise disclosure risk, data from smaller health boards were amalgamated according to geography, thereby reducing the number from 14 to 10 areas. Results A total of 17% (n= 879 492) of the Scottish population were aged ≥65 years, of which 3.7% (n= 32 368) were care home residents. In total, 12.1% (n= 106 412) of older people were prescribed one or more B&Z: 5.9% an anxiolytic, 7.5% a hypnotic, and 1.3% were prescribed both. B&Zs were prescribed to 28.4% (9199) of care home and 11.5% (97 213) of non-care home residents (relative risk = 2.88, 95% CI = 2.82 to 2.95,P<0.001). Estimated annual B&Z exposure reduced with increasing age of care home residents, whereas non-care home residents’ exposure increased with age. Conclusion B&Zs were commonly prescribed for older people, with care home residents approximately three times more likely to be prescribed B&Zs than non-care home residents. However, overall B&Z exposure among non-care home residents was found to rise with increasing age

show abstract

Section: Comparison With Existing Literaturesupporting

confidence: 64%

Section: 3 Lormetazepam (S) or Zaleplon (S)mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study

et al. 2016

View full text Add to dashboard Cite

show abstract

“…El aumento del número de prescripciones de psicofármacos en residencias de ancianos a lo largo de los últimos años en la mayoría de los países desarrollados [11][12][13] convierte a este tipo de pacientes en uno de los grupos más consumidores de estos fármacos. Este argumento, unido a la importancia de la revisión de la medicación en residencias de ancianos, ya realizada en otros países [14], integrando en estos equipos de trabajo a un farmacéutico con competencias clínicas para detectar posibles medicamentos potencialmente inadecuados (MPI) y medicamentos potencialmente omitidos (MPO), trabajando siempre en un contexto multidisciplinar junto a médicos, enfermeros y otros profesionales sanitarios, además de las frecuentes caídas que sufre la población anciana, fueron razones de peso que nos llevaron a realizar este estudio.…”

Section: Introductionunclassified

Psicofármacos y riesgo de caídas en ancianos: resultados preliminares del estudio piloto caso-control anidado en una residencia de ancianos portuguesa

Palanca¹,

Aguiar²,

Costa³

et al. 2017

View full text Add to dashboard Cite

Originales RESUMENIntroducción: Las caídas son frecuentes entre los ancianos, los cuales toman muchos medicamentos y algunos de ellos, como los psicofármacos, pueden aumentar el riesgo de caídas.Objetivos: Investigar la relación entre el uso de psicofármacos y la aparición de caídas en pacientes ancianos institucionalizados e identificar los fármacos más utilizados en estos pacientes. Además, se estudió el riesgo asociado al número de psicofármacos que el paciente estaba tomando y el riesgo de caídas que provocaron.Material y métodos: Se realizó un estudio caso-control anidado a partir de una cohorte de pacientes polimedicados internados en una residencia. Los casos fueron pacientes con caídas, entre agosto de 2014 y diciembre de 2015, y los controles aquellos que no cayeron. La exposición a psicofármacos fue investigada en los 2 grupos retrospectivamente. La información fue recogida de la base de datos de la residencia por personal sanitario. El análisis se centró en las OR de caídas por grupo terapéutico, usando un IC de 95%.Resultados: Se analizó una muestra de 22 pacientes, 9 casos y 13 controles: mayoría mujeres, y edad media 82,3 años (DE=6,5). Cada residente tomó una media de 11 medicamentos (DE=4,6). El grupo farmacoterapéutico y el fármaco más utilizados fueron antipsicóticos y quetiapina (59,1%, n=13; 45,5%, n=10, respectivamente). Los OR calculados demuestran no haber ninguna asociación estadísticamente significativa entre los subgrupos terapéuticos y/o fármacos con un elevado riesgo de caídas (p. ej. quetiapina: OR=4.5; IC=0,730-27,739; antipsicóticos atípicos: OR=3,2; IC=0,540-18,980).Conclusión: Como los resultados fueron obtenidos de una muestra limitada, no se demostraron relaciones significativas, aunque sí una clara relación entre el uso de psicofármacos y el riesgo de caídas, identificando aquellos grupos farmacoterapéuticos más influyentes en caídas. Psychopharmaceuticals and the risk of falls among elderly people: preliminary results of the nested case-control pilot study in a Portuguese care home ABSTRACTIntroduction: Falls are frequent in the elderly, because they take medication that may increase the risk of falls, including psychotropic drugs.Aims: To explore the relationship between the use of psychotropic drugs and the occurrence of falls in institutionalized patients, and to identify the most used drugs in these patients. In addition, it was studied the risk associated with the psychotropic drugs and the risk of falls that they caused. PALABRAS CLAVEAncianos, psicofármacos, caídas, farmacoepidemiología, seguimiento farmacoterapéutico, seguridad terapéutica, residencia de ancianos Financiación: Ninguna. Contribución a la autoría: MGP contribuyó al desarrollo del estudio, el análisis de los resultados, a la redacción del manuscrito y a la revisión del manuscrito final. JPA al análisis de los resultados, el tratamiento estadístico, a la redacción del manuscrito y a la revisión del manuscrito final. AMC al diseño y desarrollo del estudio, al análisis de los resultados y a la revisión del ...

show abstract

“…Indeed, there has been a clear trend toward increasing rates of psychotropic drug prescription in nursing homes over time (Ruths et al, 2012).…”

mentioning

confidence: 99%

The need for holistic management of behavioral disturbances in dementia

Macfarlane

Cunningham

2017

Int. Psychogeriatr.

View full text Add to dashboard Cite

Dementia is now the leading cause of admission to residential aged care facilities (RACF) in the developed world (Van Rensbergen and Nawrot, 2010), with prevalence rates among residents estimated to be approximately 70% (Zimmerman et al., 2014). In addition, dementia is now the 4th leading cause of death in high-income countries with this expected to rise to the 3rd leading cause of death by 2030 (World health Organization, 2015). Despite the prevalence of the condition, the amount of teaching time devoted to dementia in medical school curricula remains low and does not adequately prepare graduates for their work as doctors (Tullo and Allan, 2011; Tullo and Gordon, 2013). As a consequence, many general practitioners feel their level of confidence in managing behavioral and psychological symptoms of dementia (BPSD) is very low (Buhagiar et al., 2011).

show abstract

Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts

Abstract: Prescribing of psychotropic drugs in nursing homes has increased considerably, especially regarding antidepressants. Explanations for this trend need to be further explored.

Cited by 52 publications

References 43 publications

Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study

Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study

Psicofármacos y riesgo de caídas en ancianos: resultados preliminares del estudio piloto caso-control anidado en una residencia de ancianos portuguesa

The need for holistic management of behavioral disturbances in dementia

Contact Info

Product

Resources

About